‘An influential foundation focused on preparation and response to epidemics that is backing nine potential coronavirus vaccines has identified manufacturers with capacity to produce four billion doses a year, the group's top manufacturing expert told Reuters. The Coalition for Epidemic Preparedness Innovation (CEPI) plans to have two or three manufacturing plants for each vaccine, James Robinson, a long-time biopharma executive leading CEPI'S vast manufacturing push, said in an interview. "Right now, we know we can do the two billion doses that we have as kind of our minimum target" by the end of 2021, he said.’
Read here (Straits Times, June 25, 2020)
